Palantir's Growth Engine Shifts Gears as Commercial Clients Take Center Stage

Palantir's Q2 beat shows US commercial sales up 149%, but valuation at 139x earnings and overbought signals raise caution.

The numbers that landed on traders' screens Friday morning told a story Palantir has spent years trying to write. Revenue up 93% to $1.94 billion in the second quarter. US commercial sales accelerating at a 149% clip to $764 million. A customer base that expanded 35% to 653 commercial accounts, with 73 deals each worth at least $10 million closed during the period.

The market's response was immediate: shares jumped 9.88% to €148.84 on Friday, capping a weekly gain that one source pegs at 36.18% and another at 39.47%. Either way, it was the kind of week that rewrites a stock's narrative.

For years, the knock on Palantir was that it amounted to a high-priced consultancy with government contracts — impressive technology, but limited room to scale beyond Washington. The second-quarter report dismantles that thesis. The US commercial segment is now growing faster than the government business, which still expanded a healthy 90% to $809 million. The "Rule of 40" — a blended measure of growth and profitability — hit 155, a figure that puts Palantir in rarefied air even among the software sector's elite performers.

Bank of America responded by reaffirming its buy rating and lifting its price target to $255, roughly €215. The firm's analysts see the commercial customer expansion as the opening phase of a broader scaling story, not a one-off surge.

The Valuation Conundrum

Here's where the enthusiasm meets arithmetic. The 14-day relative strength index sits at 72.2, a textbook overbought reading. The stock trades 29.64% above its 50-day moving average of €114.81 — an unusually wide gap that historically precedes consolidation. Even after the rally, shares remain 5.27% below where they started the year and 17.30% off the November 2025 record high of €179.98.

The consensus analyst price target of €160.60 leaves just 7.9% of upside from Friday's close. That's a thin margin of safety for a stock trading at 139 times earnings — roughly six times the multiple of established software names like Salesforce, which fetches around 22 times. The market is pricing in near-flawless execution for the remainder of fiscal 2026, and perhaps beyond.

Palantir's own guidance suggests management shares some of that confidence. The company raised its 2026 revenue outlook to a range of $8.15 billion to $8.158 billion. But the elevated expectations cut both ways: any stumble in the coming quarters could trigger an outsized reaction, given the stock's annualized volatility of 100%.

A Macro Tailwind — For Now

The rally drew support from an unlikely corner. Friday's US jobs report showed a decline of 23,000 positions and an unemployment rate of 4.1% — data that would typically spook markets. Instead, weak economic readings are fueling hopes for looser monetary policy, with market expectations for a 2026 rate cut now at 56%. For a high-multiple growth stock, that's a favorable backdrop.

The stock now sits roughly 15% above its 200-day moving average, a technical signal that momentum remains intact. But the macro calendar could test that positioning. Wednesday brings the July consumer price index, expected to show a modest cooling. Thursday follows with producer prices, and Friday wraps the week with retail sales data that may reveal whether softness in the labor market is bleeding into consumer spending.

Growing Pains Beyond the Balance Sheet

Palantir's diversification push extends beyond commercial software. A confirmed partnership with Gannett, the publisher behind USA Today, will deliver "actionable insights" into reader behavior — a foray into media and consumer data analytics that mirrors an existing collaboration with Thomson Reuters.

Not everything is going smoothly, however. A Swiss commercial court in Zurich ruled against Palantir on 22 of 23 claims in a case brought by a local magazine, underscoring the company's ongoing friction with European institutions. Public criticism also persists over data-sharing arrangements between US agencies such as ICE and Medicaid.

The Insider Question

One data point gives pause: insiders sold $150.7 million worth of shares over the past 90 days. Executive selling is often routine portfolio management, and the figure alone doesn't signal distress. But following a week of gains approaching 40%, it raises a legitimate question about whether those closest to the company see the current price as fair value — or as an opportunity to lock in gains.

The bull case rests on whether Palantir's commercial momentum can sustain itself. As long as US commercial growth stays above 130%, interest in the stock should remain strong. But with a market capitalization of €357.53 billion and an overbought technical picture, the easy money from the earnings pop may already be made. The company must now demonstrate that its "Agentic AI" vision translates into durable, multi-year revenue growth — not a single spectacular quarter.